Survey Suggests Upside to Alnylam (ALNY) ALN-PCSsc Program - Jefferies
Tweet Send to a Friend
Jefferies analyst Gena Wang reiterated a Buy rating and $122 price target on Alnylam Pharmaceuticals (NASDAQ: ALNY) price target of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
